Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.

Chan, Denise Pui Chung; Wong, Ngai Sze; Wong, Bonnie C K; Chan, Jacky M C; Lee, Shui Shan

Chan, Denise Pui Chung; Wong, Ngai Sze; Wong, Bonnie C K; Chan, Jacky M C; Lee, Shui Shan.

Emerg Infect Dis ; 28(10): 2130-2132, 2022 Oct.

Article in English | MEDLINE | ID: covidwho-2022575

ABSTRACT

ABSTRACT

In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.

Subject(s)

COVID-19; HIV Infections; COVID-19/prevention & control; COVID-19 Testing; COVID-19 Vaccines; Hong Kong/epidemiology; Humans; SARS-CoV-2

Keywords

COVID-19; HIV/AIDS; Hong Kong; SARS-CoV-2; inactivated vaccine; persons living with HIV; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccines; viruses; zoonoses

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Emerg Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google